期刊文献+

Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression,angiogenesis,invasion and metastasis 被引量:10

Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression,angiogenesis,invasion and metastasis
原文传递
导出
摘要 Growing evidence suggests that myeloid-derived suppressor cells (MDSCs),which have been named "immature myeloid cells" or "myeloid suppressor cells" (MSCs),play a critical role during the progression of cancer in tumor-bearing mice and cancer patients.As their name implies,these cells are derived from bone marrow and have a tremendous potential to suppress immune responses.Recent studies indicated that these cells also have a crucial role in tumor progression.MDSCs can directly incorporate into tumor endothelium.They secret many pro-angiogenic factors as well.In addition,they play an essential role in cancer invasion and metastasis through inducing the production of matrix metalloproteinases (MMPs),chemoattractants and creating a pre-metastatic environment.Increasing evidence supports the idea that cancer stem cells (CSCs) are responsible for tumorigenesis,resistance to therapies,invasion and metastasis.Here,we hypothesize that CSCs may "hijack" MDSCs for use as alternative niche cells,leading to the maintenance of stemness and enhanced chemo-and radio-therapy resistance.The countermeasure that directly targets to MDSCs may be useful for against angiogenesis and preventing cancer from invasion and metastasis.Therefore,the study of MDSCs is important to understand tumor progression and to enhance the therapeutic efficacy against cancer. Growing evidence suggests that myeloid-derived suppressor cells (MDSCs),which have been named "immature myeloid cells" or "myeloid suppressor cells" (MSCs),play a critical role during the progression of cancer in tumor-bearing mice and cancer patients.As their name implies,these cells are derived from bone marrow and have a tremendous potential to suppress immune responses.Recent studies indicated that these cells also have a crucial role in tumor progression.MDSCs can directly incorporate into tumor endothelium.They secret many pro-angiogenic factors as well.In addition,they play an essential role in cancer invasion and metastasis through inducing the production of matrix metalloproteinases (MMPs),chemoattractants and creating a pre-metastatic environment.Increasing evidence supports the idea that cancer stem cells (CSCs) are responsible for tumorigenesis,resistance to therapies,invasion and metastasis.Here,we hypothesize that CSCs may "hijack" MDSCs for use as alternative niche cells,leading to the maintenance of stemness and enhanced chemo-and radio-therapy resistance.The countermeasure that directly targets to MDSCs may be useful for against angiogenesis and preventing cancer from invasion and metastasis.Therefore,the study of MDSCs is important to understand tumor progression and to enhance the therapeutic efficacy against cancer.
出处 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2010年第7期423-430,共8页 遗传学报(英文版)
基金 supported by the National Basic Research Program of China (973 Program) (No 2010CB529403) the National Natural Science Foundation of China (Nos 30725035 and 30930103)
关键词 myeloid-derived suppressor cells immune suppression ANGIOGENESIS INVASION METASTASIS myeloid-derived suppressor cells immune suppression angiogenesis invasion metastasis
  • 相关文献

参考文献79

  • 1Arai, K., Takano, S., Teratani, T., lto, Y., Yamada, T., and Nozawa, R. (2008). S 100AS and S l OOA9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curt. Cancer Drug Targets 8:243-252.
  • 2Balkwill, F., and Mantovani, A. (2001). Inflammation and cancer: back to Virchow? Lancet 357:539 545.
  • 3Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G., and Giavazzi, R. (2003). Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res. 63: 5224-5229.
  • 4Bosco, M.C, Pupp% M., Blengio, F., Fraone, T., Cappello, P., Giovarelli, M., and Varesio, L. (2008). Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 213: 733-749.
  • 5Bronte, V., Kasic, T., Gri, G., Gallana, K., Borsellino, G., Marigo, I., Battistini, L., lafrate, M., Prayer-Galetti, T., Pagano, F., and Viola, A. (2005). Boosting antitumor rcsponses of T lymphocytes infiltrating human prostate cancers. J. Exp. Med. 201:1257 1268.
  • 6Bunt, S.K., Sinha, P., Clements, V.K., Leips, J., and Ostrand- Rosenberg, S. (2006). Inflammation induces myeloid-defived suppressor cells that facilitate tumor progression. J. Immunol. 176: 284-290.
  • 7Cauley, L.S., ,Miller, E.E., Yen, M., and Swain, S.L. (2000). Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma. J. Imlnunol. 165: 6056-6066.
  • 8Clark, C.E., Hingorani, S.R., Mick, R., Combs, C., Tuveson, D.A., and Vonderheide, R.H. (2007). Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 67: 9518-9527.
  • 9Clarke, M.E., Dick, J.E., Dirks, P.B., Eaves, C.J., Jamieson, C.H., Jones, D.L., Visvader, J., Weissman, I.L., and Wahl, G.M. (2006). Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66: 9339-9344.
  • 10Dean, R.A., Butler, G.S., Hamma-Kourbali, Y., Delbe, J., Brigstock, D.R., Courty, J., and Overall, C.M. (2007) Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomie screens: disruption of vascular endothelial growlh factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Conncctive tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol. Cell Biol. 27: 8454-8465.

同被引文献23

引证文献10

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部